Passage Bio Inc (PASG)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $13.29M
Last updated: Nov 17, 2026 at 4:10 PM ET
Passage Bio Inc (PASG) Stock Chart
Passage Bio (PASG) has a latest price of $4.22 on Nov 17, 2026, 78.9% below its 52-week high of $20.00. Its price fell 52.3% over the past 12 months. The month-end price fell 98.0% over the 5 years through Oct 2026, a compound annual decline of 54.4%.
Price Chart
From Feb 2020 to Oct 2026, its highest month-end close was $546.60 in Jun 2020 and its lowest $3.45 in Oct 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart PASG with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for PASG.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 6.4%, and over 6 months it fell 16.9%. The month-end price fell 73.0% over the 3 years through Oct 2026, a compound annual decline of 35.4%.
| Period | Change |
|---|---|
| 1 month | +17.9% |
| 3 months | -6.4% |
| 6 months | -16.9% |
| 12 months | -52.3% |
| 12 months, with dividends | -52.3% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -73.0% | -35.4% |
| 5 years | -98.0% | -54.4% |
Price by Year
Its best calendar year was 2025, when the price rose 4.0%, and its weakest was 2022, when it fell 78.3%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $3.45 | -70.8% |
| 2025 | $11.80 | +4.0% |
| 2024 | $11.34 | -43.9% |
| 2023 | $20.20 | -26.8% |
| 2022 | $27.60 | -78.3% |
| 2021 | $127.00 | -75.2% |
Trading Range
The price is 3.3% above its 50-day average of $4.09 and 26.4% below its 200-day average of $5.74.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $4.22 | |
| 52-week high | $20.00 | -78.9% |
| 52-week low | $3.29 | +28.3% |
| 50-day average | $4.09 | +3.3% |
| 200-day average | $5.74 | -26.4% |
Price Risk
Over 3 years, its largest fall from a peak was 90.4%.
| Measure | Value |
|---|---|
| 1-year beta | 1.96 |
| Largest fall, 1 year | -83.3% |
| Largest fall, 3 years | -90.4% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About PASG
What is PASG's 1-year price change?
Passage Bio's price fell 52.3% over the past 12 months. With dividends included, the 12-month total return was -52.3%.
What is PASG's 5-year price change?
Passage Bio's month-end price fell 98.0% over the 5 years through Oct 2026, a compound annual decline of 54.4%. These figures leave out dividends.
What is PASG's 52-week high and low?
Passage Bio's 52-week high is $20.00 and its 52-week low is $3.29. Its latest price of $4.22 on Nov 17, 2026 is 78.9% below the high.
What is PASG's beta?
Passage Bio's 1-year beta against the S&P 500 is 1.96, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 83.3%.
Is the PASG chart free?
Yes. Advanced Charting for PASG is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
PASG pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors